在表皮卵巢癌中,p53的免疫组合化学和分子模式对生殖系BRCA1/2变体负

Susanna Ronchi1, Sofia Facchi1, Eleonora Di Lauro1

  • 1Unit of Pathology, Ospedale di Circolo, ASST SetteLaghi, Research Center for Familial and Hereditary Tumors, Department of Medicine and Surgery, University of Insubria, 21100 Varese, Italy.

PubMed
概括

在上皮卵巢癌 (EOC) 致癌过程中,TP53的改变是常见的早期事件,无论BRCA突变状态如何. 输卵管中异常的p53模式,包括STIC,与EOC发育有关.